期刊文献+

通痹颗粒联合甲氨喋呤对类风湿性关节炎患者血清IL-6的影响 被引量:7

Effects of Tongbi granules combined with methotrexate on IL-6 in patients with rheumatoid arthritis
下载PDF
导出
摘要 目的观察通痹颗粒联合甲氨喋呤对类风湿性关节炎血清IL-6的影响。方法将60例类风湿性关节炎患者随机分为治疗组(30例)和对照组(30例),治疗组予通痹颗粒和甲氨喋呤,对照组予甲氨喋呤,治疗3个月后分别观察两组患者给药前后血清IL-6变化情况。结果治疗组显效率为43.3%,对照组显效率为26.7%,两组比较差异具有统计学意义(P<0.05);治疗组降低血清IL-6水平亦优于对照组,差异具有统计学意义(P<0.05)。结论通痹颗粒联合甲氨喋呤能有效降低血清IL-6水平,改善患者临床症状,是类风湿性关节炎中西医结合治疗的有效方案。 Objective To investigate the effects of combined Tongbi granules(TBG) and methotrexate(MTX) on IL-6 in patients with rheumatoid arthritis(RA). Methods 60 patients with RA were randomly divided into the test group treated with TBG and MTX, and the control group with only MTX; the changes of IL-6 in two groups before and after three months were observed. Results The effectual rate in test group(43.3%) to reduce the index levels of blood IL-6 was remarkably better than that in control group(26.7%)(P〈0.05). Conclusion The troatment combined TBG and MTX is effective to reduce the level of serum IL-6, which is an effective therapy for RA.
出处 《湖南中医药大学学报》 CAS 2009年第2期52-54,共3页 Journal of Hunan University of Chinese Medicine
基金 湖南省自然科学基金资助项目(06JJ50041) 湖南省卫生厅中医药科研基金资助项目(6202) 湖南省重点学科中医内科学资助
关键词 通痹颗粒 甲氨喋呤 类风湿性关节炎 白介素-6 黄芪 当归 乳香 Tongbi granules methotrexate rheumatoid arthritis interleukin-6
  • 相关文献

参考文献9

二级参考文献18

  • 1Terlman H, Pagliari LJ, Liu H, et al. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-lβ-eonverting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis rheum,2001,44 : 21 - 30.
  • 2Gaye C, Oliver FG, Klaus NH, et al. Synovial tissue protease gene expression and join erosions in early rheumatoid arthritis. Arthritis rheum,2001,44 : 1744 - 1753.
  • 3Satoh K, Kikuchi S, Sekimata M,et al. Involvement of ErbB-2 in rheumatoid arthritis synovial cell growth. Arthritis Rheum,2001,44 : 260 - 265.
  • 4Blaschke S, Schulz H, Schwarz G, et al. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.Rheumatology, 2001,28 : 12-21.
  • 5Hang HG, Wang YM, Xie JF, et al. Regulation of tumor necrosis factoret-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis rheum,2001,44 : 1555 - 1567.
  • 6Migita K, Honda S, Yamasaki S, et al. Regulation of rheumatoid synovial cell growth by ceramide. Biochem Biophys Res Commun,2000, 269 : 70 -75.
  • 7Relic B, Guicheux J, Mezin F,et al. Il-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. Immunology, 2001,166 : 2775 - 2782.
  • 8Tak PP, Gerlay DM,Aupperle KK, et al. Inhibitor of nuclear factor κB kinase 13 is a key regulator of synovial inflammation. Arthritis Rheum,2001,44 : 1897 - 1907.
  • 9Takeba Y, Suzuki N, Wakisaka S, et al. Involvement of cAMP responsive element binding protein (CREB) in the synovial cell hyperfunction in patients with rheumatoid arthritis. Clin Exp Rheumatol, 2000,18 : 47 -55.
  • 10Chou CT, Yang JS, Lee MR. Apoptosis in rheumatoid arthritis-expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. Pathology, 2001,193 : 110- 116.

共引文献66

同被引文献107

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部